Title:
VEGF-BINDING MOLECULE AND PHARMACEUTICAL USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/155918
Kind Code:
A1
Abstract:
The present disclosure provides a VEGF-binding molecule and a pharmaceutical use thereof. In particular, the present disclosure relates to a VEGF-binding molecule, a nucleic acid encoding the VEGF-binding molecule, a vector comprising the nucleic acid, and a pharmaceutical use.
Inventors:
YUAN XIAOJING (CN)
ZHANG WENTAO (CN)
LU CHENG (CN)
ZHANG WEI (CN)
NING WEI (CN)
ZHOU CAIHONG (CN)
LIAO CHENG (CN)
ZHANG WENTAO (CN)
LU CHENG (CN)
ZHANG WEI (CN)
NING WEI (CN)
ZHOU CAIHONG (CN)
LIAO CHENG (CN)
Application Number:
PCT/CN2023/077365
Publication Date:
August 24, 2023
Filing Date:
February 21, 2023
Export Citation:
Assignee:
SHANGHAI REGENELEAD THERAPIES CO LTD (CN)
International Classes:
C07K19/00; A61K38/17; A61P27/02; C07K14/005; C07K16/22; C12N15/86
Foreign References:
| CN101838329A | 2010-09-22 | |||
| CN110423281A | 2019-11-08 | |||
| CN101397343A | 2009-04-01 | |||
| US20140213769A1 | 2014-07-31 |
Attorney, Agent or Firm:
GE CHENG & CO., LTD. et al. (CN)
Download PDF: